Latest Ceo Appointments News

The week was split between big earnings reactions and small-cap rocks-and-rigs rallies. Pro Medicus sank despite record numbers, while a handful of explorers jumped on fresh discoveries and policy wins.

Healthcare stocks split into two stories this week: big names sold off hard, while a few small caps ran on clear news. The biggest moves came from a sharp fall in Pro Medicus and Cochlear, while Noxopharm jumped after a top-tier journal publication.

Big moves came from disclosure drama, CEO change news, and one standout software upgrade. While several stocks jumped on results, a few gaps couldn’t hold as traders sold into early strength.

PeopleIN Limited has appointed co-founder Tom Reardon as its new CEO and Managing Director, signaling continuity in leadership as the company reports a robust unaudited EBITDA of $16.1 million.

Minbos Resources has appointed Rob Newbold as Acting CEO following the resignation of Lindsay Reed, while grappling with administrative and shareholder challenges delaying its key phosphate project in Angola.

Tamboran Resources has marked significant milestones in the Beetaloo Basin with successful drilling, major capital raises, and a new CEO appointment, targeting first gas sales in Q3 2026.

Patrys Limited has appointed Dr Samantha South as its new CEO, aiming to leverage her biotech expertise to fast-track clinical development and commercialisation of its therapeutic antibody pipeline.

Domino’s Pizza Enterprises has appointed Andrew Gregory, a seasoned McDonald’s executive, as its new Group CEO and Managing Director, effective by August 2026. This leadership change aims to drive franchisee profitability and disciplined growth across Domino’s global network.

Bravura Solutions reports robust half-year growth with nearly 10% revenue increase, a fresh leadership appointment, and strategic expansion into the UK pensions market.

Bravura Solutions reported a solid 9.8% increase in underlying revenue for the half-year ending December 2025, despite the absence of prior non-recurring licence sale income. The company also announced a new CEO appointment and declared both interim and special dividends.

RLF AgTech has appointed Stuart Upton as CEO, marking a strategic shift towards disciplined execution and commercial scaling of its crop nutrition and carbon platforms. Former Acting Managing Director Gavin Ball returns to Executive Director to focus on international expansion.

A single exploration name blew the doors off the leaderboard, while two well-known uranium plays and a Nevada explorer sank hard. Behind the noise: deals got closer to completion, big raisings reset prices, and several “good news” gaps didn’t survive the week.